Literature DB >> 30567936

Poly(ADP-Ribose) Polymerases in Host-Pathogen Interactions, Inflammation, and Immunity.

Pamlea N Brady1, Anupam Goel2, Margaret A Johnson3.   

Abstract

The literature review presented here details recent research involving members of the poly(ADP-ribose) polymerase (PARP) family of proteins. Among the 17 recognized members of the family, the human enzyme PARP1 is the most extensively studied, resulting in a number of known biological and metabolic roles. This review is focused on the roles played by PARP enzymes in host-pathogen interactions and in diseases with an associated inflammatory response. In mammalian cells, several PARPs have specific roles in the antiviral response; this is perhaps best illustrated by PARP13, also termed the zinc finger antiviral protein (ZAP). Plant stress responses and immunity are also regulated by poly(ADP-ribosyl)ation. PARPs promote inflammatory responses by stimulating proinflammatory signal transduction pathways that lead to the expression of cytokines and cell adhesion molecules. Hence, PARP inhibitors show promise in the treatment of inflammatory disorders and conditions with an inflammatory component, such as diabetes, arthritis, and stroke. These functions are correlated with the biophysical characteristics of PARP family enzymes. This work is important in providing a comprehensive understanding of the molecular basis of pathogenesis and host responses, as well as in the identification of inhibitors. This is important because the identification of inhibitors has been shown to be effective in arresting the progression of disease.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  ADP-ribosylation; antiviral responses; autoimmunity; enzyme inhibition; host-pathogen interactions; inflammation; poly(ADP-ribose); poly(ADP-ribose) polymerases; stress granules; transcriptional regulation

Mesh:

Substances:

Year:  2018        PMID: 30567936      PMCID: PMC6383445          DOI: 10.1128/MMBR.00038-18

Source DB:  PubMed          Journal:  Microbiol Mol Biol Rev        ISSN: 1092-2172            Impact factor:   11.056


  14 in total

1.  The PARP inhibitor olaparib exerts beneficial effects in mice subjected to cecal ligature and puncture and in cells subjected to oxidative stress without impairing DNA integrity: A potential opportunity for repurposing a clinically used oncological drug for the experimental therapy of sepsis.

Authors:  Akbar Ahmad; Juliana de Camargo Vieira; Aline Haas de Mello; Thais Martins de Lima; Suely Kubo Ariga; Denise Frediani Barbeiro; Hermes Vieira Barbeiro; Bartosz Szczesny; Gábor Törö; Nadiya Druzhyna; Elisa B Randi; Michela Marcatti; Tracy Toliver-Kinsky; András Kiss; Lucas Liaudet; Reinaldo Salomao; Francisco Garcia Soriano; Csaba Szabo
Journal:  Pharmacol Res       Date:  2019-05-06       Impact factor: 7.658

Review 2.  PARP Inhibitors: An Innovative Approach to the Treatment of Inflammation and Metabolic Disorders in Sepsis.

Authors:  Weronika Wasyluk; Agnieszka Zwolak
Journal:  J Inflamm Res       Date:  2021-05-06

Review 3.  ADP-ribosylation in evasion, promotion and exacerbation of immune responses.

Authors:  Maria Manuela Rosado; Claudio Pioli
Journal:  Immunology       Date:  2021-04-12       Impact factor: 7.215

Review 4.  Targeting ADP-ribosylation as an antimicrobial strategy.

Authors:  Giuliana Catara; Annunziata Corteggio; Carmen Valente; Giovanna Grimaldi; Luca Palazzo
Journal:  Biochem Pharmacol       Date:  2019-06-06       Impact factor: 5.858

5.  Effects of Poly (ADP-ribose) Polymerase Inhibition on DNA Integrity and Gene Expression in Ovarian Follicular Cells in Mice with Endotoxemia

Authors:  Olena Kondratska; Nataliya Grushka; Svitlana Pavlovych; Nataliya Krasutska; Serhii Tsyhankov; Roman Yanchii
Journal:  Iran Biomed J       Date:  2022-01-01

Review 6.  PARP-1-Associated Pathological Processes: Inhibition by Natural Polyphenols.

Authors:  Natalya V Maluchenko; Alexey V Feofanov; Vasily M Studitsky
Journal:  Int J Mol Sci       Date:  2021-10-23       Impact factor: 5.923

Review 7.  NAD+ in COVID-19 and viral infections.

Authors:  Minyan Zheng; Michael B Schultz; David A Sinclair
Journal:  Trends Immunol       Date:  2022-02-11       Impact factor: 16.687

8.  PARP-1 regulates inflammasome activity by poly-ADP-ribosylation of NLRP3 and interaction with TXNIP in primary macrophages.

Authors:  Ling-Ya Chiu; Duen-Yi Huang; Wan-Wan Lin
Journal:  Cell Mol Life Sci       Date:  2022-01-30       Impact factor: 9.261

Review 9.  PARP Power: A Structural Perspective on PARP1, PARP2, and PARP3 in DNA Damage Repair and Nucleosome Remodelling.

Authors:  Lotte van Beek; Éilís McClay; Saleha Patel; Marianne Schimpl; Laura Spagnolo; Taiana Maia de Oliveira
Journal:  Int J Mol Sci       Date:  2021-05-12       Impact factor: 5.923

Review 10.  The Role of PARPs in Inflammation-and Metabolic-Related Diseases: Molecular Mechanisms and Beyond.

Authors:  Yueshuang Ke; Chenxin Wang; Jiaqi Zhang; Xiyue Zhong; Ruoxi Wang; Xianlu Zeng; Xueqing Ba
Journal:  Cells       Date:  2019-09-06       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.